Jie Mao

564 total citations
9 papers, 235 citations indexed

About

Jie Mao is a scholar working on Cancer Research, Molecular Biology and Immunology. According to data from OpenAlex, Jie Mao has authored 9 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Jie Mao's work include IL-33, ST2, and ILC Pathways (2 papers), Cancer-related molecular mechanisms research (2 papers) and MicroRNA in disease regulation (2 papers). Jie Mao is often cited by papers focused on IL-33, ST2, and ILC Pathways (2 papers), Cancer-related molecular mechanisms research (2 papers) and MicroRNA in disease regulation (2 papers). Jie Mao collaborates with scholars based in China, Australia and Saudi Arabia. Jie Mao's co-authors include Wang Wang, Yong Xu, Yifan Xiao, Huoying Chen, Zheng Tan, Junyu Shi, Yan Chen, Fang Zheng, Lin Chen and Feili Gong and has published in prestigious journals such as Clinical Cancer Research, Journal of Investigative Dermatology and Theranostics.

In The Last Decade

Jie Mao

7 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Mao China 7 117 92 73 30 26 9 235
Julie Coudenys Belgium 10 93 0.8× 148 1.6× 44 0.6× 49 1.6× 25 1.0× 18 327
Thinh H. Nguyen United States 10 157 1.3× 43 0.5× 56 0.8× 59 2.0× 24 0.9× 23 279
Yilang Tang Germany 8 92 0.8× 147 1.6× 41 0.6× 47 1.6× 20 0.8× 11 296
Atsushi Kawakami Japan 7 162 1.4× 116 1.3× 42 0.6× 66 2.2× 26 1.0× 13 312
Ann-Christin Frank Germany 7 217 1.9× 215 2.3× 161 2.2× 60 2.0× 13 0.5× 8 408
Qianru Huang China 8 110 0.9× 105 1.1× 32 0.4× 51 1.7× 18 0.7× 13 245
So‐Hee Ahn South Korea 10 264 2.3× 42 0.5× 131 1.8× 21 0.7× 22 0.8× 13 334
Joanna Dong United States 7 152 1.3× 70 0.8× 20 0.3× 47 1.6× 24 0.9× 24 310
Erdong Shen China 9 169 1.4× 41 0.4× 131 1.8× 41 1.4× 56 2.2× 20 281

Countries citing papers authored by Jie Mao

Since Specialization
Citations

This map shows the geographic impact of Jie Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Mao more than expected).

Fields of papers citing papers by Jie Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Mao. The network helps show where Jie Mao may publish in the future.

Co-authorship network of co-authors of Jie Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Mao. A scholar is included among the top collaborators of Jie Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Mao. Jie Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
3.
Mao, Jie, Xiaoli Zhang, Ping Wang, et al.. (2023). CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer. Digestive and Liver Disease. 56(2). 330–342. 32 indexed citations
4.
Wang, Wang, et al.. (2021). Naringin promotes osteogenesis and ameliorates osteoporosis development by targeting JAK2/STAT3 signalling. Clinical and Experimental Pharmacology and Physiology. 49(1). 113–121. 36 indexed citations
5.
Chen, Huoying, Lan Chen, Jie Mao, et al.. (2020). An Autocrine Circuit of IL-33 in Keratinocytes Is Involved in the Progression of Psoriasis. Journal of Investigative Dermatology. 141(3). 596–606.e7. 40 indexed citations
6.
Wang, Xu, Jie Mao, Tao Zhou, et al.. (2020). Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment. Theranostics. 11(1). 209–221. 40 indexed citations
7.
Jiang, Bin, Jie Xu, Yifei Zhou, et al.. (2020). Estrogen Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Activating the Wnt/β-Catenin Signaling Pathway. Journal of Craniofacial Surgery. 31(2). 583–587. 13 indexed citations
8.
Liang, Yu, Di Wu, Hugh Gao, et al.. (2018). Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer. Clinical Cancer Research. 24(6). 1459–1472. 39 indexed citations
9.
Xiao, Yifan, Huoying Chen, Junyu Shi, et al.. (2018). Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells. Molecular Immunology. 101. 550–563. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026